<scp>ASP</scp>8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with <i><scp>EGFR</scp></i> mutation‐positive non‐small‐cell lung cancerKoichi Azuma, Kazuhiko Nakagawa, Makoto Nishio et al.|Cancer Science|2018Cited by 35
OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M MutationsK. Park, Kazuhiko Nakagawa, Hiroshi Nokihara et al.|Journal of Thoracic Oncology|2017Cited by 1